Literature DB >> 8694037

Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women.

S Rasheed1, Z Li, D Xu, A Kovacs.   

Abstract

OBJECTIVE: The purpose of this study was to establish virologic or molecular criteria for evaluating the rate of transmission of human immunodeficiency virus type 1 and for defining the role of virus burden in the development of gynecologic diseases in human immunodeficiency virus-infected women. STUDY
DESIGN: Paired samples of blood and cervicovaginal secretions from 63 human immunodeficiency virus-seropositive women were evaluated for cell-free and cell-associated virus load by several methods, including quantitative cultures and reverse transcription polymerase chain reaction.
RESULTS: All women showed evidence of virus infection in both blood and cervicovaginal secretions by a combination of in vitro culture and molecular detection methods. The CD4+ cell counts in these women ranged from < 200/microliter to > 500/microliter. Blood plasma of 26% women (12/46) did not show detectable levels of human immunodeficiency virus ribonucleic acid by reverse transcription polymerase chain reaction (< 10(2)/100 microliters). These same women had significant amounts of human immunodeficiency virus in the cell-free cervicovaginal secretions (10(2) to 10(5) copies per 100 microliters). In contrast, 17% (8/46) women with significant quantity of human immunodeficiency virus ribonucleic acid in the blood plasma had negative results for human immunodeficiency virus in the cervicovaginal secretions. Further, treatment of women with the antiviral drug zidovudine did not change the human immunodeficiency virus-1 detection rate in plasma ribonucleic acid but showed significant reduction in the ability to detect human immunodeficiency virus ribonucleic acid in cell-free cervicovaginal secretions (p = 0.036).
CONCLUSIONS: We conclude that the replication kinetics of human immunodeficiency virus in the blood and cervicovaginal cells are unrelated, independent events. Further, there is no correlation between the virus load or the CD4+ cell counts in the blood and the presence or absence of quantifiable human immunodeficiency virus in cervicovaginal secretions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694037     DOI: 10.1016/s0002-9378(96)70261-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Dilution assessment of cervicovaginal secretions collected by vaginal washing to evaluate mucosal shedding of free human immunodeficiency virus.

Authors:  A S Mohamed; P Becquart; H Hocini; P Métais; M Kazatchkine; L Bélec
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

2.  Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments.

Authors:  R N Shepard; J Schock; K Robertson; D C Shugars; J Dyer; P Vernazza; C Hall; M S Cohen; S A Fiscus
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 3.  British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998).

Authors:  G P Taylor; E G Lyall; D Mercey; R Smith; T Chester; M L Newell; G Tudor-Williams
Journal:  Sex Transm Infect       Date:  1999-04       Impact factor: 3.519

Review 4.  Primary HIV infection--a public health opportunity.

Authors:  W Cates; M A Chesney; M S Cohen
Journal:  Am J Public Health       Date:  1997-12       Impact factor: 9.308

5.  Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group.

Authors:  P Baron; J Bremer; S S Wasserman; M Nowicki; B Driscoll; B Polsky; A Kovacs; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

Review 6.  Advances in prevention of mother-to-child HIV transmission: the international perspectives.

Authors:  Chokechai Rongkavilit; Basim I Asmar
Journal:  Indian J Pediatr       Date:  2010-10-16       Impact factor: 1.967

Review 7.  Advances in prevention of mother-to-child HIV transmission.

Authors:  Chokechai Rongkavilit; Basim I Asmar
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

8.  Quantitation of human immunodeficiency virus type 1 RNA loads in cervicovaginal secretions in pregnant women and relationship between viral loads in the genital tract and blood.

Authors:  S García-Bujalance; G Ruiz; C Ladrón De Guevara; J M Peña; I Bates; J J Vázquez; A Gutiérrez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-20       Impact factor: 3.267

9.  Efficient isolation of human immunodeficiency virus type 1 RNA from cervical swabs.

Authors:  A M Hajjar; P F Lewis; Y Endeshaw; J Ndinya-Achola; J K Kreiss; J Overbaugh
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.